Peter Barton Hutt

Peter Barton Hutt is a Partner specializing in food and drug law in the Washington, D.C. law firm of ovington & Burling. He served as Chief Counsel for the FDA from 1971-1975 and is the co-author of a casebook used to teach food and drug law throughout the country.

Mr. Hutt currently serves on the Boards of Directors of several public and privately-held biotechnology companies, including CV Therapeutics, Inc. and Cognetix, Inc., and venture capital advisory boards, including Polaris Venture Partners and the Sprout Group. He has previously served as a director of other companies, including IDEC Pharmaceuticals Corporation (now Biogen IDEC Inc.) during its development of Rituxan®.

Mr. Hutt has served on many advisory committees including the Advisory Committee to the Director of the National Institutes of Health (NIH), the NIH Advisory Committee to Review the Guidelines for Recombinant DNA Research, and five Office of Technology Assessment advisory panels.